celastrol (UoM/Univalor/NEOMED)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug Namecelastrol (UoM/Univalor/NEOMED)
Drug Alias NameHsp90 inhibitors (University of Montreal)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHeat shock protein HSP90 modulatorsHeat shock protein HSP90 inhibitors
TargetsHeat shock protein HSP90
Therapy Area/IndicationsMyocardial Reperfusion InjuryNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversite De Montreal
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversite De MontrealUnivalorNeomed Institute
Active IndicationsN/A
Inactive IndicationsMyocardial Reperfusion InjuryNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A